Coronary Interventions Don't Cut Deaths
A new report finds that more coronary interventions such as stents or angioplasty have not significantly reduced heart attack deaths. This challenges assumptions that procedural interventions alone improve outcomes, reinforcing the need for broader lifestyle-based prevention and long-term management approaches. The findings question current cardiology treatment priorities.
- The report from the EAPCI Summit 2026 analyzed data from 21 European countries and found that a higher number of percutaneous coronary interventions (PCIs) was associated with an increase in age-standardized heart attack mortality, after adjusting for socioeconomic factors and the prevalence of cardiovascular disease. - The lead presenter of the study, Ali Malik of King's College London, noted that there is significant regional and national variability in how PCI is delivered and in patient outcomes, suggesting that procedural volume alone doesn't guarantee better results. - Senior author Dr. Sanjay Sivalokanathan from the Mount Sinai Health System pointed to the global rise in risk factors like diabetes and obesity, which increases the clinical complexity of patients and makes interventions more challenging. - For patients with stable coronary artery disease, quitting smoking can reduce the risk of major cardiovascular events, including death or heart attack, by 44%. - Comprehensive cardiac rehabilitation, which includes exercise, education, and psychological support, has been shown to lower the risk of death by 47% and the risk of heart attack by 31% for individuals who complete 36 sessions. - Despite the proven benefits of cardiac rehabilitation, utilization remains low, with studies showing that only about 34-36% of heart attack survivors participate in a program. - Engaging in 150-300 minutes of vigorous physical activity per week is associated with a 27-33% lower risk of death from cardiovascular disease. - Adherence to prescribed medications for coronary artery disease is crucial; one study found that overall adherence to cardiovascular medications was only 57% after two years, with better adherence being associated with a lower risk of major cardiovascular events.
